was a significant correlation between the pooled free serum and total muscle concentrations for cefazoin (P = 0.001); however, there was no correlation between these variables with the pooled cefuroxime data (P = 0.403). These findings indicate that'the free drug concentration in serum alone is not consistently predictive of the total concentration of cephalosporin in muscle.
Although the relationships between the total and free drug concentrations in serum and their concurrent concentrations in tissues have been the object of much study, these relationships remain uncertain, and their clinical significance is controversial. Studies of antimicrobial tissue penetration have typically utilized a single dose of antimicrobial agent administered via a short intravenous (i.v.) infusion.
The goal of the present study was to assess under steadystate conditions the effect of serum protein binding on the tissue penetration of two cephalosporins, cefazolin and cefuroxime, administered by continuous i.v. infusion. The specific objectives of this study were to determine the concentrations of free and total drug in serum and total drug in muscle by using a continuous-infusion model in patients undergoing orthopedic surgery and to determine the relationships between these concentrations. Cefazolin and cefuroxime were selected as study drugs based on considerations for patient safety and differences in serum protein binding. Cefazolin is considered a drug of choice for'surgical prophylaxis in total hip replacement and internal fixation of fractures, and cefuroxime has also been effective for these purposes (1, 6, 15 The continuous i.v. infusion of cefazolin or cefuroxime was initiated 12 or 14 h, respectively, before the start of the operation to allow adequate time for the attainment of steady-state conditions before biologic sampling in the operating room. The study drug was infused via a syringe pump (Auto Syringe model AS2F; Travenol Laboratories, Hooksett, N.H.). Once the infusion was initiated, the rate was held constant until the infusion was discontinued in the postoperative recovery room.
Biologic sampling and drug assays. Venous blood samples of 10 ml were obtained at the time of the initial surgical incision and at wound closure. The serum was harvested and stored in glass vials at -80°C until assayed. A 1-g sample of viable muscle was obtained from the surgical site concurrent with the blood samples. Muscle samples were blotted dry with surgical gauze and stored at -80°C.
The concentrations of free and total drug in serum and total drug in homogenized muscle were determined by high-performance liquid chromatography (HPLC). The International Equipment Co., Needham Heights, Mass.) at 3,000 rpm for 10 min, and 10 RI of the clear eluent was injected onto the HPLC column. The concentration of free cefazolin in serum was obtained by ultrafiltration with an Amicon MPS filter system with a YMT membrane (Amicon Corp., Danvers, Mass.). Serum (1 ml) was centrifuged at 3,000 rpm for 6 min to yield 150 ,u of ultrafiltrate. Then 25 ,u of 8-chlorotheophylline internal standard (100,ug/ml) was added to 100 RI of protein-free filtrate and vortexed, and 10 ,lI was injected onto the HPLC column. To determine the total concentration of cefazolin in muscle, 2 ml of Sorensen phosphate buffer (pH 7.4) was added to 500 mg of frozen muscle. The frozen muscle sample was placed in an ice bath and homogenized for less than 1 min with a tissue homogenizer (Tissumizer TRST; Tekmar Co., Cincinnati, Ohio). The homogenate was vortexed and then centrifuged for 10 min at 3,000 rpm. Solid-phase extraction of cefazolin from the homogenate was done on a C18 column (Prep-sep; Fisher Scientific Co., Pittsburgh, Pa.) by taking 500 RI of eluent from the centrifuged homogenate and washing it with 1 ml of purified water on the column, followed by extraction of the drug from the column with 1 ml of methanol. Then 20 RI of 8-chlorotheophylline internal standard (50 ,ug/ml) was added to 500 ,ul of the resulting eluent and vortexed, and 30 RI was injected onto the HPLC column.
The concentrations of total and free cefuroxime in serum and the concentration of total cefuroxime in muscle were determined as described above for cefazolin. 8-Chlorotheophylline was the internal standard for all cefuroxime assays.
The standard curve ranges for the cefazolin assays were 10 to 100 ,ug/ml, 2 to 30 ,ug/ml, and 2 to 15 ,ug/g for the total and free drug concentrations in serum and total drug concentration in muscle, respectively. The ranges for the standard curves of the cefuroxime assays were 10 to 100 ,ug/ml, 5 to 50 ,g/ml, and 2 to 50 ,ug/g for the total and free drug concentrations in serum and total drug concentration in muscle, respectively. The standard curve for each of the study drugs in muscle was prepared with porcine muscle. Because of the limited amount of clinical material (0.5 to 1 g), drug stability tests were not undertaken. The sensitivities were 1 jig/ml and 1 ,ug/g for all serum and muscle assays, respectively.
The r2 for the standard curves ranged from 0.990 to 0.999.
The intraday coefficients of variation were 5.9 and 8.9% for cefazolin and cefuroxime in muscle at 2 ,ug/g, respectively.
For serum (total and free), they were usually less than 5%.
Data analysis. Mean concentration data obtained at surgical incision and wound closure were compared within subjects by using paired t tests. Comparisons between drugs were performed with independent t tests. The associations between concentrations were tested with the Pearson correlation coefficient. Two-tailed tests were used for all comparisons, and the a priori level of statistical significance was set at P< 0.05.
RESULTS
Of the 34 patients enrolled in the study, 5 were withdrawn for the following reasons: inability to start an i.v. to administer the study drug (2 patients), malfunction of the i.v. infusion pump (1 patient), inability to maintain the infusion (1 patient), and failure to begin the infusion at the proper time (1 patient). Of the 29 evaluable subjects, 14 received cefazolin and 15 received cefuroxime. Subjects in the two study groups did not differ significantly (P > 0.05) with regard to the following (means + standard deviations): age (cefazolin, 48.1 + 12.5 years; cefuroxime, 45.9 + 17.6 years), calculated creatinine clearance (cefazolin, 76.6 ± 25.6 mlmin; cefuroxime, 88.5 + 26.4 mlmin) and serum albumin (cefazolin, 4.8 + 0.5 g/dl; cefuroxime, 4.5 + 0.4 g/dl). The mean infusion rates of cefazolin and cefuroxime were 178.6 ± 46.9 and 330.0 + 114.6 mg/h, respectively (P< 0.001). The mean duration of surgery for subjects receiving cefazolin and cefuroxime was 94.2 ± 21.5 and 105.4 + 32.8 min, respectively (P > 0.05). Surgical procedures were begun between 8:00 a.m. and 2:00 p.m. and used a variety of anesthetic agents.
The mean concentration data obtained at surgical incision and wound closure for both antibiotics are summarized in Table 1 . Comparisons within subjects of cefazolin concentrations obtained at incision and wound closure were not significant (P > 0.05). However, there were significant intrasubject differences in the cefuroxime total serum (P < 0.05), free serum (P < 0.01), and total muscle (P = 0.001) concentrations at incision and wound closure. The concentrations of total cefazolin and cefuroxime in muscle were not statistically different (surgical incision, P = 0.74; wound closure, P = 0.86) despite significant differences between drugs in both total and free drug concentrations in serum. For cefazolin, there were significant correlations between total and free drug concentrations in serum at both surgical incision and wound closure and between free drug concentration in serum and total concentration in muscle at surgical incision. At wound closure, the correlation between free cefazolin concentration in serum and total concentration in muscle also approached statistical significance (P = 0.059). For cefuroxime, the only significant correlations were between total and free concentrations in serum at surgical incision and wound closure (Table 2) . When the incision and closure concentration data for each drug were pooled, there were significant correlations between total and free concentrations in serum for both cefazolin and cefuroxime and between the concentration offree cefazolin in serum and total concentration in muscle (Table 3) .
DISCUSSION
Generally it is believed that only free, unbound antimicrobial agents are able to interact with microorganisms to exert a pharmacologic effect (17) . Most pathogenic bacteria reside in tissue sites outside of the vascular system; therefore, the tissue penetration of free drug is important for drug efficacy. In the present study we utilized a continuous i.v. infusion under steady-state conditions to control for the total concen- Although the mean total concentration of cefazolin in serum closely approximated the target concentration of 50 jig/ml, the mean total concentration of cefuroxime in serum fell considerably short of this goal. The reasons for not achieving the target concentration are not apparent but may relate to one of the components used to estimate cefuroxime clearance.
The bacteria most frequently associated with deep wound infections after orthopedic surgery are Staphylococcus aureus and Staphylococcus epidermidis (1) . For cefuroxime, the MICs for 90% of S. aureus and S. epidermidis isolates are 1.4 and 0.98 ,ug/ml, respectively (10) . Ninety-six percent of S. aureus isolates and 94% of S. epidermidis isolates are inhibited by cefazolin concentrations of 2.0 and 4.0 ,ug/ml, respectively (12) . The concentration of cefuroxime in muscle exceeded the MIC for 90% of staphylococci in all subjects. Of 14 subjects receiving cefazolin, 1 had drug concentrations in muscle of less than 2 jig/g, and 3 had drug concentrations of less than 4 ,ug/g (range, 1.3 to 3.9 jig/g). No postoperative infections were noted in either study group. The optimal antimicrobial concentration in tissue for preventing postoperative infection and its relationship to the MIC for potentially infecting organisms are still unknown. The significant differences in cefuroxime concentrations at the times of surgical incision and wound closure were an unexpected finding and indicate a change from the steady state. The increased cefuroxime concentrations at closure may have been due to intraoperative changes in drug clearance. Cefazolin and cefuroxime are both eliminated renally via glomerular filtration and tubular secretion. The renal clearances of cefazolin and cefuroxime are 50 to 62 and 150 ml/min per 1.73 m2, respectively (8) . General anesthetics have been shown to cause intraoperative reductions in renal blood flow and the glomerular filtration rate (5, 9, 14) , and cefuroxime, having a significantly higher renal clearance, would be expected to be affected by these intraoperative changes to a greater extent than cefazolin.
We assessed antimicrobial tissue penetration by mechanically homogenizing wound muscle. As with any method of determining antimicrobial tissue penetration, tissue homogenization has certain limitations. First, blood may contaminate the tissue sample, resulting in a falsely elevated concentration of drug in tissue (2) . Second, the process of homogenizing the tissue disturbs the anatomical relationships within the tissue, resulting in a dilutional effect on antibiotic in the extracellular space and underestimation of the antibiotic concentration at the site of most bacterial infections (13, 16) . Previous experiences with the methods employed in this study have found blood contamination of muscle tissue to be negligible (7) . Although tissue homogenization may result in underestimation of the antibiotic concentration in the extracellular space, both study drugs should be affected equally by this procedure.
Although the present study found a good correlation between free drug in serum and total drug in muscle for cefazolin, there was no such correlation for cefuroxime.
Also, cefazolin and cefuroxime concentrations in muscle were similar, despite significantly different free drug concentrations in serum. These findings indicate that the free drug concentration in serum alone is not a consistent predictor of the total concentration in tissue. Further studies are needed to determine the clinical significance of this finding.
